University of Leeds Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Hull Featured PhD Programmes
"systems" AND "engineerin…×
10 miles

Cancer / Oncology (systems engineering) PhD Projects, Programs & Scholarships

We have 15 Cancer / Oncology (systems engineering) PhD Projects, Programs & Scholarships

  • "systems" AND "engineering" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 15 of 15
  Understanding the mechanisms of ultrasound and microbubble mediated targeted drug delivery
  Dr H Mulvana, Dr J Jackson
Application Deadline: 28 February 2020

Funding Type

PhD Type

PhD studentship. University of Strathclyde Student Excellence Award. Understanding the mechanisms of ultrasound and microbubble mediated targeted drug delivery.
  Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
  Dr F Greco, Prof H Osborn
Applications accepted all year round

Funding Type

PhD Type

Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier.
  Raman and Fluorescence Signals for Clinical Optical Imaging
  Dr R.K Henderson, Dr N Finlayson
Application Deadline: 30 May 2020

Funding Type

PhD Type

The EPSRC IRC Proteus (Proteus) - Multiplexed ’Touch and Tell’ Optical Molecular Sensing and Imaging - Lifetime and Beyond” is an Interdisciplinary Research Collaboration between the Universities of Edinburgh, Bath, Heriot Watt, Durham and Dundee.
  Carbohydrate analysis for biomedical applications.
  Dr S Allman
Applications accepted all year round

Funding Type

PhD Type

Changes in the patterns of carbohydrates produced by the cell can provide insights into disease states, revealing perturbations and differences in cellular metabolic processes.
  Cationic antimicrobial peptides as anticancer agents
  Dr R Green, Prof R A Frazier
Applications accepted all year round

Funding Type

PhD Type

Cationic peptides are widespread in nature where they play a key role in host defense within plants and animals. The mechanism by which these peptides interact with cell membranes potentially leads to these being less prone to antimicrobial resistance than conventional antibiotics.
  Design and synthesis of novel, targeted, anti-cancer agents
  Prof H Osborn, Dr F Greco
Applications accepted all year round

Funding Type

PhD Type

One of the major problems of cancer chemotherapy is that the drugs used have poor selectivities for cancer cells and cause damage to normal cells and organs.
  Mechanisms of Cancer Stem Cell Survival, Metastasis Formation and Immune Evasion in Cancer
  Dr D Widera
Applications accepted all year round

Funding Type

PhD Type

Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells.
  Modelling stem cell fate and alterations due to mutations
  Dr E Morrissey
Application Deadline: 24 July 2020

Funding Type

PhD Type

The group uses a combination of deep learning, stochastic models and Bayesian modelling to study questions relating to stem cell fate dynamics and how mutations in stem cells alter their normal behaviour, become fixed and accumulate in the tissue eventually leading to cancer.
  Modelling stem cell fate and alterations due to mutations
  Dr E Morrissey
Application Deadline: 24 July 2020

Funding Type

PhD Type

The group uses a combination of deep learning, stochastic models and Bayesian modelling to study questions relating to stem cell fate dynamics and how mutations in stem cells alter their normal behaviour, become fixed and accumulate in the tissue eventually leading to cancer.
  Nano-engineered Delivery Systems for the Targeted Delivery of Oncology Drugs for Non-Small Cell Lung Cancer
  Dr H McCarthy, Dr N Buckley
Applications accepted all year round

Funding Type

PhD Type

Lung cancer is the most common cancer worldwide accounting for 11.6% of the global burden. The standard of care (SoC) chemotherapy typically involves a ‘cocktail’ of drugs which confer debilitating side-effects, resulting in sub-optimal dosing with a reduced clinical efficacy.
  Carbon Nanotubes Mediated Drug Delivery in 3D cancer models
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

Current treatment with anticancer drugs suffers from the drawbacks of systemic toxicity, drug resistance and limited cellular entry.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  High-throughput mechanobiology
  Dr C Toseland
Applications accepted all year round

Funding Type

PhD Type

Cancer research has traditionally focused upon extra- or intra-cellular biochemical signals, and their relation to cancer development and metastasis.
  Personalised Medicine for Breast and Ovarian Cancer
  Dr N Buckley, Dr H McCarthy
Applications accepted all year round

Funding Type

PhD Type

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.